title: Acid aspiration prophylaxis in labour: a survey of UK obstetric units.
abstract: BACKGROUND
  The risk of acid aspiration is still a major concern in pregnant patients. In view of the increasing numbers of drugs available to decrease gastric acid production, it seemed timely to reassess acid aspiration prophylaxis policies in the UK.
  
  
  METHODS
  An OAA-approved postal survey of 250 UK lead consultant obstetric anaesthetists was conducted in 2004 in order to establish the current practice of acid aspiration prophylaxis in labour. If acid aspiration prophylaxis was used, further questions were asked relating to subgroups of patients, category, dose and route of administration of drugs used and whether there was an anticipated change in practice.
  
  
  RESULTS
  A response rate of 83% was achieved. There had been a decrease in the routine use of acid aspiration prophylaxis to 32% of units, an increase in the use of acid aspiration prophylaxis in "at risk" groups to 61% and a decrease in the number of units never using prophylaxis to 7%. Oral ranitidine administered six-hourly is the most common practice. There is little use of proton pump inhibitors.
  
  
  CONCLUSIONS
  Compared to previous surveys of UK practice there has been an overall increase in the use of acid aspiration prophylaxis.
authors.affiliation: Anaesthetics Department, Birmingham Women's Hospital, Birmingham, UK. nicolawild@doctors.org.uk
authors.forename: N
authors.initials: N
authors.lastname: Calthorpe
authors.forename: M
authors.initials: M
authors.lastname: Lewis
mesh_terms: D000863:Antacids / Q000627:therapeutic use; D003625:Data Collection; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007744:Obstetric Labor Complications / Q000517:prevention & control*; D011015:Pneumonia, Aspiration / Q000517:prevention & control*; D011247:Pregnancy; D006113:United Kingdom
chemical_list: D000863:Antacids; D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists